TY - JOUR
T1 - Isooctane-based anionic and zwitterionic surfactant
T2 - Synergistic interaction of mixed reverse micelle and solubilisation of erythromycin
AU - Mohamad-Aziz, Siti Norazimah
AU - Mishra, Puranjan
AU - Zularisam, A. W.
AU - Sakinah, A.M. Mimi
N1 - Funding Information:
The authors are thankful to the Faculty of Engineering Technology, for providing technical and financial assistance to Universiti Malaysia Pahang, Malaysia (UMP-PGRS-160361).
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/7/15
Y1 - 2019/7/15
N2 - In the present study, the reverse micelle of anionic (sodium bis(2-ethylhexyl)sulfosuccinate)(AOT)and zwitterionic (3-N, N-Dimethyllaurylammonio propanesulfonate)(SB3–12)surfactants was mixed in an isooctane organic phase, and their behaviour towards solubilisation of erythromycin was investigated. Erythromycin is used as an alternative for gram-positive infections in patients resistant to, or allergic to penicillin for skin treatment, soft tissue infection, mycoplasma pneumonia and legionella disease. The critical micelle concentration of the mixture (CMCmix)was analysed by applying phase separation and Rubingh's model of the surfactants to evaluate the synergistic effect between AOT and SB3–12 in isooctane solution. The critical micelle concentration of AOT and SB3–12 was 22.5 g/L and 0.9 g/L, respectively in isooctane phase. The critical micelle concentration of the mixed AOT/SB3–12 reverse micelle was 0.70 g/L. The mixed reverse micelle has efficiently increased the solubility of erythromycin, by which 94.2% transfer was achieved from 0.8:0.2 proportion of AOT to SB3–12. Thermodynamic parameters describing the free energy of micelle formation (ΔGm)and standard Gibbs free energy of adsorption (ΔGads)were found to be negative which suggest that micellization and adsorption were spontaneous. The excess Gibbs free energy of mixing (ΔGo ex)value indicates that the formation of the AOT/SB3–12 mixed reverse micelle was thermodynamically stable. Conclusively, the mixed reverse micelle enhances erythromycin solubilisation in isooctane organic phase at low surfactant concentration, and the synergism of the combination between AOT and SB3–12 was positive.
AB - In the present study, the reverse micelle of anionic (sodium bis(2-ethylhexyl)sulfosuccinate)(AOT)and zwitterionic (3-N, N-Dimethyllaurylammonio propanesulfonate)(SB3–12)surfactants was mixed in an isooctane organic phase, and their behaviour towards solubilisation of erythromycin was investigated. Erythromycin is used as an alternative for gram-positive infections in patients resistant to, or allergic to penicillin for skin treatment, soft tissue infection, mycoplasma pneumonia and legionella disease. The critical micelle concentration of the mixture (CMCmix)was analysed by applying phase separation and Rubingh's model of the surfactants to evaluate the synergistic effect between AOT and SB3–12 in isooctane solution. The critical micelle concentration of AOT and SB3–12 was 22.5 g/L and 0.9 g/L, respectively in isooctane phase. The critical micelle concentration of the mixed AOT/SB3–12 reverse micelle was 0.70 g/L. The mixed reverse micelle has efficiently increased the solubility of erythromycin, by which 94.2% transfer was achieved from 0.8:0.2 proportion of AOT to SB3–12. Thermodynamic parameters describing the free energy of micelle formation (ΔGm)and standard Gibbs free energy of adsorption (ΔGads)were found to be negative which suggest that micellization and adsorption were spontaneous. The excess Gibbs free energy of mixing (ΔGo ex)value indicates that the formation of the AOT/SB3–12 mixed reverse micelle was thermodynamically stable. Conclusively, the mixed reverse micelle enhances erythromycin solubilisation in isooctane organic phase at low surfactant concentration, and the synergism of the combination between AOT and SB3–12 was positive.
KW - Critical micelle concentration (CMC)
KW - Erythromycin solubilisation
KW - Ionic-zwitterionic
KW - Mixed reverse micelle
KW - Surfactant adsorption
UR - http://www.scopus.com/inward/record.url?scp=85065549699&partnerID=8YFLogxK
U2 - 10.1016/j.molliq.2019.110882
DO - 10.1016/j.molliq.2019.110882
M3 - Journal article
SN - 0167-7322
VL - 286
JO - Journal of Molecular Liquids
JF - Journal of Molecular Liquids
M1 - 110882
ER -